A Study of BMS-863233 in Patients With Hematologic Cancer

Clinical trial NCT00838890 · TERMINATED

Trial details

NCT number: NCT00838890
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory Hematologic Cancer

Start date: 2009-03-01
Primary completion: 2010-01-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.